Evidence map›Paper›PMID 36819287›Full record

ArticleQuantitative imaging in medicine and surgery2023

Abdominal virtual non-contrast images derived from energy spectrum CT to evaluate chemotherapy-related fatty liver disease.

Mengyuan Jing, Jiachen Sun, Huaze Xi, Zhuoheng Liu, Shuai Zhang, Liangna Deng, Tao Han, Bin Zhang, Xiaoqiang Lin, Junlin Zhou

Open access · diamondAbstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Quantitative imaging in medicine and surgery · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mengyuan Jing *Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Jiachen Sun *Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Huaze XiDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Zhuoheng LiuComputed Tomography Research Center, GE Healthcare China, Beijing, China.
Shuai ZhangComputed Tomography Research Center, GE Healthcare China, Beijing, China.
Liangna DengDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Tao HanDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Bin ZhangDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Xiaoqiang LinDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Junlin ZhouDepartment of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
Lanzhou University Second Hospital · CNLanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chemotherapy-related fatty liver disease (CRFLD) is an important evaluation in patients undergoing computed tomography (CT) for cancer follow-up. This study set out to explore the feasibility of using abdominal virtual non-contrast (VNC) images derived from energy spectrum CT to evaluate CRFLD and reduce the radiation dose. Methods: A total of 160 eligible consecutive patients who underwent energy spectrum CT at Lanzhou University Second Hospital between June 2020 and July 2021 were retrospectively enrolled. The average CT attenuation values of the liver and spleen and the liver-to-spleen ratio (LSR) were measured by two independent blinded radiologists on true non-contrast (TNC) images and three types of VNC image. The diagnostic performance of the LSR for CRFLD, image quality, and diagnostic confidence were compared between the two types of imaging. Results: The average CT attenuation values of the liver and spleen were significantly lower on VNC images than on TNC images (P<0.05), whereas the LSR showed good agreement between the two (P>0.05). The average CT attenuation values of the liver and the LSR measured on the TNC and three types of VNC image were significantly lower in patients with CRFLD than in those without CRFLD (P<0.001). The area under the curve (AUC) values of the LSR for the diagnosis of CRFLD calculated on TNC and three types of VNC image were 0.870 (95% CI: 0.808-0.918), 0.852 (95% CI: 0.787-0.903), 0.819 (95% CI: 0.750-0.875), and 0.851 (95% CI: 0.786-0.902), respectively. The DeLong test confirmed the consistency of TNC and VNC images of diagnostic efficacy (P>0.05). There were no significant differences in image quality or diagnostic confidence between the TNC and three types of VNC image (P>0.05). When VNC imaging was applied, the radiation dose was reduced by approximately 25.0%. Conclusions: VNC imaging could become a reliable alternative to TNC imaging for the clinical evaluation of patients with CRFLD and could reduce the radiation dose by up to 25%.

Indexed as

chemotherapy-related fatty livercomputed tomography attenuation valueEnergy spectrum computed tomographyvirtual non-contrast (VNC)

Identifiers

PMID36819287
PMCPMC9929393
OpenAlexW4313456119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.